Prosecution Insights
Last updated: July 17, 2026
Application No. 18/125,245

CYCLODEXTRIN COMPOSITIONS, ARTICLES, AND METHODS

Final Rejection §102
Filed
Mar 23, 2023
Priority
Mar 27, 2011 — provisional 61/468,041 +7 more
Examiner
KOSACK, JOSEPH R
Art Unit
3991
Tech Center
3900
Assignee
Verdant Technologies LLC
OA Round
2 (Final)
75%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
69%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
967 granted / 1292 resolved
+14.8% vs TC avg
Minimal -6% lift
Without
With
+-5.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
17 currently pending
Career history
1307
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
34.4%
-5.6% vs TC avg
§102
21.0%
-19.0% vs TC avg
§112
19.8%
-20.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1292 resolved cases

Office Action

§102
DETAILED ACTION Claims 26-50 are pending in the present application. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Amendments The amendment filed on August 19, 2025 was acknowledged and has been entered into the present application file. Priority The present application is a CON of 17/149,172, now USPN RE49,501, which was filed on January 14, 2021. As the present application is a Bauman continuation of a reissue application, the original patent is available as prior art and the effective filing date of the present application does not extend beyond the actual filing date of the reissue application. See In re Bauman, 683 F.2d 405, 214 USPQ 585 (CCPA 1982). Claim Objections The numbering of claims is not in accordance with 37 CFR 1.126 which requires the original numbering of the claims to be preserved throughout the prosecution. When claims are canceled, the remaining claims must not be renumbered. When new claims are presented, they must be numbered consecutively beginning with the number next following the highest numbered claims previously presented (whether entered or not). Misnumbered claims 22-46 been renumbered 26-50. Claim Rejections - 35 USC §102 The following is a quotation of the appropriate paragraphs of 35 USC §102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 26-50 are rejected under 35 USC §§102(a)(1) and 102(a)(2) as being clearly anticipated by US Patent 10,182,567 (WOOD). This application is a Bauman-type application per the analysis detailed above, thus, the original patent is prior art and therefore clearly anticipates the claims. Response to Arguments On pages 9-10 of the remarks of August 19, 2025, the Applicant argues: PNG media_image1.png 356 546 media_image1.png Greyscale PNG media_image2.png 68 542 media_image2.png Greyscale However, on June 15, 2026, the petition to convert the present application from a Bauman Continuation to a Continuing Reissue was denied. Therefore, the ‘567 patent is still prior art and the rejection is maintained with respect to the renumbered claims. Conclusion Claims 26-50 are rejected. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Joseph Kosack whose telephone number is (571)272-5575. The examiner can normally be reached M-F 8:00-4:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Patricia Engle can be reached at 571-272-6660. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOSEPH R KOSACK/Patent Reexamination Specialist Central Reexamination Unit 3991 /Alan Diamond/ Patent Reexamination Specialist Central Reexamination Unit 3991
Read full office action

Prosecution Timeline

Mar 23, 2023
Application Filed
Apr 29, 2025
Non-Final Rejection mailed — §102
Aug 19, 2025
Response Filed
Jun 24, 2026
Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12649804
Polymeric Compound, Electroluminescent Device Material, Electroluminescent Device, and Electronic Device
3y 5m to grant Granted Jun 09, 2026
Patent RE50878
PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS
3y 1m to grant Granted May 05, 2026
Patent RE50800
PRO-FRAGRANCE COMPOUNDS
3y 5m to grant Granted Feb 17, 2026
Patent RE50725
Thickener Composition, Thickened Nutritive Products, Methods For Preparing Thickened Nutritive Products, And Methods For Providing Nutrition
2y 1m to grant Granted Jan 06, 2026
Patent RE50703
POLYMER COMPOSITION
2y 7m to grant Granted Dec 16, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
75%
Grant Probability
69%
With Interview (-5.6%)
2y 7m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1292 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month